A groundbreaking cancer detection study published in Cell [1] cites the use of HemaCare-sourced human bone marrow.
The Cell publication is part of a global collaborative effort based in 8 different countries, including several U.S. based cancer research institutes. Their goal is simple; find a way to detect cancer early, no matter where it originates in the human body, thereby securing the best possible chance of treating patients successfully.